Press Releases
Ceapro Inc. Announces Signing of a Contribution Agreement with National Research Council of Canada
Ceapro Announces Results of 2019 Shareholders’ Meeting
Ceapro Presents Positive Results from Avenanthramides Study at the 2019 American Society of Sports Medicine Meeting
Ceapro Inc. Commences Patient Enrollment in First-in-Human Clinical Study Assessing Beta Glucan as a Cholesterol-Lowering Agent
Ceapro Inc. Reports 2019 First Quarter Financial Results and Highlights
Ceapro Inc. Announces Receipt of Site License from Health Canada
Ceapro Inc. to Present at the ThinkEquity Conference in New York City
Ceapro Inc. Announces Positive Key Findings from Three Oral Presentations Given at European Meeting on Supercritical Fluids
Ceapro Inc. Reports Fourth Quarter and Full Year 2018 Results and Highlights
